Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001140361-16-071788

Options or other derivatives

  • Director bought 100,000 shares

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KIRK RANDAL J Director 2016-06-30 Purchase · Series 1 Preferred Stock +100,000 100,000 I
Loading xslF345X03/doc1.xml…